CRRT is a medical therapy used in intensive care units to manage patients with acute kidney injury (AKI) or severe kidney dysfunction. It involves the continuous removal of waste products and excess fluids from the blood.

CRRT is used when a patient’s kidneys are unable to adequately filter waste and excess fluids from the blood, leading to dangerous levels of toxins and fluid overload.

CRRT differs from hemodialysis in that it is slower and performed continuously over 24 hours or longer periods. Hemodialysis, on the other hand, is intermittent and typically lasts for a few hours.

Yes, CRRT can be used cautiously in patients with heart failure to manage fluid overload and electrolyte imbalances, with careful monitoring of hemodynamic status.

CRRT provides gentler and more gradual fluid and solute removal, making it suitable for hemodynamically unstable patients who cannot tolerate the rapid changes associated with conventional hemodialysis.

The test helps diagnose rheumatoid arthritis by detecting specific antibodies associated with the condition.

A blood sample is collected and analyzed to measure the levels of anti-CCP antibodies.

No special preparation is required. You can eat and drink normally before the test.

Results are typically available within a few hours to 24 hours after the sample is processed.

Elevated levels suggest a higher likelihood of rheumatoid arthritis, but further clinical evaluation is needed for a definitive diagnosis.

Deep brain stimulation surgery involves implanting a device that sends electrical impulses to specific brain areas to regulate abnormal activity and manage symptoms.